Post-earnings recap
Reported
Thu, Aug 1, 2019
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
50%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Bio-Rad Laboratories reported a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 1.44%. This could suggest that investors were looking for more comprehensive guidance or revenue figures, which were not disclosed.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.57 | N/A | +9.51% |
Overall, management expressed confidence in the company's strategic direction. They emphasized the importance of maintaining momentum in their core markets.
Management highlighted strong performance in key segments.
They noted ongoing investments in innovation to drive future growth.